Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD

Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic moderate-to-very-severe COPD patients receiving tiotropium...

詳細記述

保存先:
書誌詳細
出版年:NPJ Prim Care Respir Med
主要な著者: Bansal, Sandeep, Anderson, Martin, Anzueto, Antonio, Brown, Nicola, Compton, Chris, Corbridge, Thomas C., Erb, David, Harvey, Catherine, Kaisermann, Morrys C., Kaye, Mitchell, Lipson, David A., Martin, Neil, Zhu, Chang-Qing, Papi, Alberto
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8149706/
https://ncbi.nlm.nih.gov/pubmed/34035312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-021-00241-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料